Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emricasan in Cirrhotic Subjects With Portal Hypertension
NCT02230683Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Aug 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in Portal Hypertension (PH), Liver cirrhosis (LC), sponsored by Conatus Pharmaceuticals Inc.. Started Aug 2014; status: completed.
02
Drugs
emricasan
03
Conditions
Portal Hypertension (PH)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02230683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230683.